蚌埠医学院学报
蚌埠醫學院學報
방부의학원학보
ACTA ACADEMIAE MEDICINAE BENGBU
2014年
12期
1671-1673
,共3页
张景俊%徐晖%程亮%潘松%吴鸿浩
張景俊%徐暉%程亮%潘鬆%吳鴻浩
장경준%서휘%정량%반송%오홍호
雷米芬太尼%丙泊酚%靶控输注%熵指数%效应室浓度
雷米芬太尼%丙泊酚%靶控輸註%熵指數%效應室濃度
뢰미분태니%병박분%파공수주%적지수%효응실농도
remifentanil%propofol%target-controlled infusion%entropy%effect compartment concentration
目的::观察丙泊酚靶控输注( TCI)诱导期间泵注雷米芬太尼对丙泊酚效应室浓度( EC)、熵指数和心血管反应的影响。方法:将择期手术患者22例,随机均分为观察组和对照组。2组均以血浆血药浓度为靶目标进行TCI,丙泊酚靶控血药初始浓度设为1.5μg/ml,每4 min增加0.5μg/ml,当改良警觉/镇静评分(MOAA/S)为1分时,对照组和观察组分别静脉泵入0.9%氯化钠注射液和雷米芬太尼0.2μg·kg-1·min-1,当MOAA/S为0分时给予肌松药3 min后行气管插管。观察记录丙泊酚EC、熵指数[反应熵( RE)、状态熵( SE)]、平均动脉压( MAP)和心率( HR),于诱导前( T0)、气管插管前3 min即给肌松药时(T1)、插管即刻(T2)、插管后1 min(T3)。结果:观察组T1~T3丙泊酚EC均低于对照组(P<0.05~P<0.01)。2组T1~T3 RE和SE差异均无统计学意义(P>0.05)。观察组T3 MAP和T1~T3 HR均明显低于对照组(P<0.01)。结论:丙泊酚TCI诱导期间泵入雷米芬太尼使麻醉深度不变的情况下丙泊酚用量明显减少,血压和HR被抑制更明显。
目的::觀察丙泊酚靶控輸註( TCI)誘導期間泵註雷米芬太尼對丙泊酚效應室濃度( EC)、熵指數和心血管反應的影響。方法:將擇期手術患者22例,隨機均分為觀察組和對照組。2組均以血漿血藥濃度為靶目標進行TCI,丙泊酚靶控血藥初始濃度設為1.5μg/ml,每4 min增加0.5μg/ml,噹改良警覺/鎮靜評分(MOAA/S)為1分時,對照組和觀察組分彆靜脈泵入0.9%氯化鈉註射液和雷米芬太尼0.2μg·kg-1·min-1,噹MOAA/S為0分時給予肌鬆藥3 min後行氣管插管。觀察記錄丙泊酚EC、熵指數[反應熵( RE)、狀態熵( SE)]、平均動脈壓( MAP)和心率( HR),于誘導前( T0)、氣管插管前3 min即給肌鬆藥時(T1)、插管即刻(T2)、插管後1 min(T3)。結果:觀察組T1~T3丙泊酚EC均低于對照組(P<0.05~P<0.01)。2組T1~T3 RE和SE差異均無統計學意義(P>0.05)。觀察組T3 MAP和T1~T3 HR均明顯低于對照組(P<0.01)。結論:丙泊酚TCI誘導期間泵入雷米芬太尼使痳醉深度不變的情況下丙泊酚用量明顯減少,血壓和HR被抑製更明顯。
목적::관찰병박분파공수주( TCI)유도기간빙주뢰미분태니대병박분효응실농도( EC)、적지수화심혈관반응적영향。방법:장택기수술환자22례,수궤균분위관찰조화대조조。2조균이혈장혈약농도위파목표진행TCI,병박분파공혈약초시농도설위1.5μg/ml,매4 min증가0.5μg/ml,당개량경각/진정평분(MOAA/S)위1분시,대조조화관찰조분별정맥빙입0.9%록화납주사액화뢰미분태니0.2μg·kg-1·min-1,당MOAA/S위0분시급여기송약3 min후행기관삽관。관찰기록병박분EC、적지수[반응적( RE)、상태적( SE)]、평균동맥압( MAP)화심솔( HR),우유도전( T0)、기관삽관전3 min즉급기송약시(T1)、삽관즉각(T2)、삽관후1 min(T3)。결과:관찰조T1~T3병박분EC균저우대조조(P<0.05~P<0.01)。2조T1~T3 RE화SE차이균무통계학의의(P>0.05)。관찰조T3 MAP화T1~T3 HR균명현저우대조조(P<0.01)。결론:병박분TCI유도기간빙입뢰미분태니사마취심도불변적정황하병박분용량명현감소,혈압화HR피억제경명현。
Objective:To investigate the effect of remifentanil on the effect compartment concentration( EC) ,response entropy( RE) , state entropy(SE) and hemodynamical response during propofol target-controlled infusion(TCI) general anesthesia period. Methods:Twenty-two ASA classⅠ - II patients undergoing elective surgery were randomly divided into the experimental group and control group,eleven cases in each group. In the two groups,the plasma concentration was as the target objective to do TCI. The initial plasma concentration was set to 1. 5μg /ml,increased by 0. 5μg /ml every 4 minutes until the Modified Observer Assessment of Alertness and Sedation(MOAA/S) score=1. The patients in experimental group were received with remifentanil infusion at 0. 2 μg·kg-1·min-1, while the patients in control group were received with normal saline at 0. 2 μg·kg-1 ·min-1 . Tracheal intubation was operated after 3 minutes with muscular relaxants when MOAA/S was equal to 0. Propofol EC,RE,SE,mean arterial pressure(MAP) and heart rate ( HR) were recorded when anesthesia was inducted with propofol TCI, including before anesthesia ( T0 ) , at the time of infusion with muscle relaxants(T1),at the time of intubation(T2) and at 1 min after intubation(T3). Results:Propofol EC in experimental group was lower than that in control group at T1 -T3(P<0. 05 to P<0. 01). There was no significant difference of RE and SE at T1 -T3 between the two groups(P>0. 05). MAP at T3 and HR at T1 -T3 in experimental group were lower than those in control group(P<0. 01). Conclusions:The doseage of propofol was decreased obviously during induction of general anesthesia by infusing remifentanil and propofol. At same time,HR and BP were inhibited obviously,but no changes of RE and SE.